LXRX
Price
$1.11
Change
+$0.02 (+1.82%)
Updated
Sep 2, 04:47 PM (EDT)
Capitalization
399.74M
58 days until earnings call
PLRX
Price
$1.67
Change
+$0.03 (+1.83%)
Updated
Sep 2, 04:57 PM (EDT)
Capitalization
100.68M
70 days until earnings call
Interact to see
Advertisement

LXRX vs PLRX

Header iconLXRX vs PLRX Comparison
Open Charts LXRX vs PLRXBanner chart's image
Lexicon Pharmaceuticals
Price$1.11
Change+$0.02 (+1.82%)
Volume$33.37K
Capitalization399.74M
Pliant Therapeutics
Price$1.67
Change+$0.03 (+1.83%)
Volume$771
Capitalization100.68M
LXRX vs PLRX Comparison Chart in %
Loading...
LXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LXRX vs. PLRX commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LXRX is a Hold and PLRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (LXRX: $1.10 vs. PLRX: $1.64)
Brand notoriety: LXRX and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LXRX: 42% vs. PLRX: 38%
Market capitalization -- LXRX: $399.74M vs. PLRX: $100.68M
LXRX [@Biotechnology] is valued at $399.74M. PLRX’s [@Biotechnology] market capitalization is $100.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LXRX’s FA Score shows that 1 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • LXRX’s FA Score: 1 green, 4 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, LXRX is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LXRX’s TA Score shows that 4 TA indicator(s) are bullish while PLRX’s TA Score has 6 bullish TA indicator(s).

  • LXRX’s TA Score: 4 bullish, 4 bearish.
  • PLRX’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than LXRX.

Price Growth

LXRX (@Biotechnology) experienced а -7.56% price change this week, while PLRX (@Biotechnology) price change was +13.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.61%. For the same industry, the average monthly price growth was +22.16%, and the average quarterly price growth was +32.80%.

Reported Earning Dates

LXRX is expected to report earnings on Oct 30, 2025.

PLRX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+6.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LXRX($400M) has a higher market cap than PLRX($101M). LXRX YTD gains are higher at: 48.951 vs. PLRX (-87.547). LXRX has higher annual earnings (EBITDA): -107.44M vs. PLRX (-201.76M). PLRX has more cash in the bank: 263M vs. LXRX (139M). LXRX has less debt than PLRX: LXRX (57M) vs PLRX (60.4M). LXRX has higher revenues than PLRX: LXRX (58.4M) vs PLRX (0).
LXRXPLRXLXRX / PLRX
Capitalization400M101M396%
EBITDA-107.44M-201.76M53%
Gain YTD48.951-87.547-56%
P/E RatioN/AN/A-
Revenue58.4M0-
Total Cash139M263M53%
Total Debt57M60.4M94%
FUNDAMENTALS RATINGS
LXRX: Fundamental Ratings
LXRX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
20
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LXRXPLRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
82%
Bullish Trend 5 days ago
73%
MACD
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 5 days ago
75%
Advances
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 14 days ago
86%
Bearish Trend 14 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
87%
Bullish Trend 5 days ago
79%
Aroon
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 5 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
LXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESGH5.560.03
+0.54%
ESG Inc.
SMSMY9.16N/A
N/A
Sims Ltd
CEVMY23.60N/A
N/A
CTS Eventim AG & Co. KGAA
CRSXQ0.15N/A
N/A
Corsa Coal Corp.
IDCBY14.65-0.24
-1.64%
Industrial and Commercial Bank of China Ltd.

LXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXRX has been loosely correlated with PLRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LXRX jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXRX
1D Price
Change %
LXRX100%
-4.35%
PLRX - LXRX
39%
Loosely correlated
+1.23%
OCUL - LXRX
36%
Loosely correlated
-2.48%
RAPP - LXRX
36%
Loosely correlated
+4.94%
TECH - LXRX
34%
Loosely correlated
+0.55%
EPIX - LXRX
34%
Loosely correlated
+2.13%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with OCUL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+1.23%
OCUL - PLRX
41%
Loosely correlated
-2.48%
SRRK - PLRX
40%
Loosely correlated
-1.89%
LXRX - PLRX
39%
Loosely correlated
-4.35%
RIGL - PLRX
38%
Loosely correlated
-1.17%
SLDB - PLRX
37%
Loosely correlated
-2.49%
More